Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study

Antifungal prophylaxis (AFP) is recommended by international guidelines for patients with acute myeloid leukaemia (AML) undergoing induction chemotherapy and allogeneic hematopoietic cell transplantation. Nonetheless, treatment of breakthrough fungal infections remains challenging. This observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangneux, Jean-Pierre, Padoin, Christophe, Michallet, Mauricette, Saillio, Emeline, Kumichel, Alexandra, Peffault de La Tour, Régis, Ceballos, Patrice, Gastinne, Thomas, Pigneux, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712136/
https://www.ncbi.nlm.nih.gov/pubmed/33198192
http://dx.doi.org/10.3390/jof6040281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712136/
https://www.ncbi.nlm.nih.gov/pubmed/33198192
http://dx.doi.org/10.3390/jof6040281

Ejemplares similares